LIFYORLI

This brand name is authorized in United States.

Active ingredients

The drug LIFYORLI contains one active pharmaceutical ingredient (API):

`1`	Relacorilant UNII `2158753C7E` - RELACORILANT
	Relacorilant is a reversible glucocorticoid receptor (GR) antagonist. In functional in vitro assays with the mineralocorticoid receptor, relacorilant showed no agonist or antagonist activity. In human cell-line derived xenograft models, relacorilant enhanced apoptosis and antitumor activity when administered with paclitaxel.
	Read more about Relacorilant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LIFYORLI Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	76346-425, 76346-450, 76346-525, 76346-550

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.